Intraperitoneal Chemotherapy of Ovarian Cancer: A Review, With a Focus on Practical Aspects of Treatment
- 20 February 2006
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (6), 988-994
- https://doi.org/10.1200/jco.2005.05.2456
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancerGynecologic Oncology, 2005
- Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients: 10-year results of a prospective randomised phase III study comparing carboplatin–cisplatin with cyclophosphamide–cisplatinEuropean Journal Of Cancer, 2003
- Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian CancerGynecologic Oncology, 2002
- Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian CancerGynecologic Oncology, 1998
- A Retrospective Review of Paclitaxel-Associated Gastrointestinal Necrosis in Patients with Epithelial Ovarian CancerGynecologic Oncology, 1997
- High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-upGynecologic Oncology, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Intestinal Perforation Secondary to PaclitaxelGynecologic Oncology, 1995
- Feasibility of Intraoperative Administration of Chemotherapy for Gynecologic Malignancies: Assessment of Acute Postoperative MorbidityGynecologic Oncology, 1993
- Intraperitoneal therapy for treatment of malignant disease principally confined to the peritoneal cavityCritical Reviews in Oncology/Hematology, 1993